Autore C - Search Results

1

Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator.

Francia P, Ziacchi M, Adduci C, Ammendola E, Pieragnoli P, De Filippo P, Rapacciuolo A, Rella V, Migliore F, Viani S, Musumeci MB, Biagini E, Lovecchio M, Baldini R, Falasconi G, Autore C, Biffi M, Cecchi F. Francia P, et al. Among authors: autore c. Europace. 2023 Aug 2;25(9):euad270. doi: 10.1093/europace/euad270. Europace. 2023. PMID: 37724686 Free PMC article.

2

Clinical relevance of the electrocardiogram in relatives of patients with hypertrophic cardiomyopathy.

Fragola PV, Autore C, Ruscitti G, Picelli A, Borzi M, Cannata D, Sangiorgi M. Fragola PV, et al. Among authors: autore c. G Ital Cardiol. 1988 Jan;18(1):52-4. G Ital Cardiol. 1988. PMID: 3384248

3

Hypertrophic cardiomyopathy in a patient with Down's syndrome.

Assenza GE, Autore C, Marino B. Assenza GE, et al. Among authors: autore c. J Cardiovasc Med (Hagerstown). 2007 Jun;8(6):463-4. doi: 10.2459/01.JCM.0000269712.86134.48. J Cardiovasc Med (Hagerstown). 2007. PMID: 17502765

4

Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, De Santis M, Quarta G, Nistri S, Cecchi F, Salton CJ, Udelson JE, Manning WJ, Maron BJ. Olivotto I, et al. Among authors: autore c. J Am Coll Cardiol. 2008 Aug 12;52(7):559-66. doi: 10.1016/j.jacc.2008.04.047. J Am Coll Cardiol. 2008. PMID: 18687251 Free article.

5

Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option?

Conti E, Musumeci MB, Assenza GE, Quarta G, Autore C, Volpe M. Conti E, et al. Among authors: autore c. Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):258-71. doi: 10.2174/187152508785909456. Cardiovasc Hematol Agents Med Chem. 2008. PMID: 18855638 Review.

6

Syncope and risk of sudden death in hypertrophic cardiomyopathy.

Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barillà CS, Biagini E, Quarta G, Conte MR, Bruzzi P, Maron BJ. Spirito P, et al. Among authors: autore c. Circulation. 2009 Apr 7;119(13):1703-10. doi: 10.1161/CIRCULATIONAHA.108.798314. Epub 2009 Mar 23. Circulation. 2009. PMID: 19307481

7

Severe left ventricular wall thinning and extensive fibrosis without evolution to end stage disease in a patient with hypertrophic cardiomyopathy.

Assenza GE, Spirito P, Musumeci MB, Lombardi M, Quarta G, Autore C. Assenza GE, et al. Among authors: autore c. J Am Soc Echocardiogr. 2009 Oct;22(10):1196.e1-2. doi: 10.1016/j.echo.2009.04.011. J Am Soc Echocardiogr. 2009. PMID: 19801310

8

Erythropoietin and the heart: facts and perspectives.

Mastromarino V, Volpe M, Musumeci MB, Autore C, Conti E. Mastromarino V, et al. Among authors: autore c. Clin Sci (Lond). 2011 Jan;120(2):51-63. doi: 10.1042/CS20100305. Clin Sci (Lond). 2011. PMID: 20929439 Review.

9

IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.

Conti E, Musumeci MB, De Giusti M, Dito E, Mastromarino V, Autore C, Volpe M. Conti E, et al. Among authors: autore c. Clin Sci (Lond). 2011 May;120(9):377-402. doi: 10.1042/CS20100400. Clin Sci (Lond). 2011. PMID: 21244364 Review.

10

High risk for sudden death identified by electrocardiographic loop recording in a patient with hypertrophic cardiomyopathy without major risk factors.

Musumeci MB, Spirito P, Cauti FM, Autore C. Musumeci MB, et al. Among authors: autore c. Am J Cardiol. 2011 May 15;107(10):1558-60. doi: 10.1016/j.amjcard.2011.01.034. Epub 2011 Mar 17. Am J Cardiol. 2011. PMID: 21420061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page